Compounds of formula (I) ##STR00001## are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved.
The present application is a divisional application of U.S. application Ser. No. 09/074,693, filed May 8, 1998 now U.S. Pat. No. 6,451,824, the disclosure of which is incorporated in its entirety herein by reference.
